Our powerful combination of quality products and extensive sales and marketing capabilities sets us apart from our competitors in the Middle East and North Africa.
Strong brands can gain significant market share in the MENA Region where, for the most part, the markets focus on branded generic products. We have some of the strongest brands in the region and a long-standing reputation for quality products.
Our large and experienced sales force is unique in the MENA region, with near 1,100 Branded and Injectables sales and marketing representatives operating across nearly 20 countries. Through their efforts we have established strong relationships with physicians, hospitals, pharmacies and purchasing groups for hospitals across the region. These relationships, combined with our commitment to quality, explain how our products have been able to become market leaders. Three of Hikma’s top ten selling products in Jordan, for example, are ranked in the top three by sales in their respective therapeutic categories.
Our strong position in the MENA Region also makes us an attractive partner for multinational pharmaceutical companies seeking access to this region – as our portfolio of under licence products demonstrates. These partnerships also help to enhance our reputation in the market as a quality producer and market leader.
We currently sell 40 products under licence or promotion and distribution agreements in the MENA region - including 33 Branded and 7 Injectable products. A further five in-licensed products are pending launch.